Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer

WEDNESDAY, Feb. 27, 2019 -- For patients with advanced Merkel cell carcinoma (aMCC), pembrolizumab is associated with durable tumor control and favorable overall survival, according to a study published online Feb. 7 in the Journal of Clinical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news